Goal 3: Advance Translational Research

Submitted by (@efimov)

NHLBI Cardiovascular Engineering Strategy

Most impressive and impactful advances in CV diagnostics and therapies came in the last 50 years from CV engineering, including implantable devices and imaging technology. CV engineers are developing next breakthrough technology including tissue engineering and flexible electronics. However, organizational structure of NIH does not have an entity responsible for strategic development of CV engineering. NIBIB does not ...more »

Voting

8 net votes
17 up votes
9 down votes
Active

Goal 2: Reduce Human Disease

Submitted by (@nhlbiforumadministrator)

Detection of rupture prone small aortic aneurysms

Critical challenges in the assessment of aortic aneurysms are: (1) Availability of reliable animal models that simulate the human pathology, (2) Availability of molecular imaging resources – identification of biomarkers, development of targeted imaging probes and pre-clinical imaging methods, and plasma markers that predict whether an aneurysm is prone to rupture or dissection, (3) Bringing together a wide array of multi-disciplinary ...more »

Voting

7 net votes
18 up votes
11 down votes
Active

Goal 2: Reduce Human Disease

Submitted by (@nhlbiforumadministrator1)

Patient-Specific Blueprints to Guide Cardiac Surgery

In order to increase the success of robotic mitral valve repair, we need to stimulate a fusion of multi-modal functional imaging with 3-D valve models that can accurately predict valve shape and closure throughout the cardiac cycle, then develop surgical “blueprints” that overlay incision and suture maps on the surgeon’s console to guide perioperative robotic repair.

Voting

-19 net votes
6 up votes
25 down votes
Active

Goal 2: Reduce Human Disease

Submitted by (@dpinsky)

Can one integrate cardiac imaging studies with genetic,clinical, "omics", and historical data to predict disease and personalize

There are many novel imaging modalities, including radiographic, scintigraphic, sonographic, MR-based, and molecular for the heart and vessels. Patients have unique medical "signatures"- genetic risk factor profiles, epigenetic markings, "omics" profiles, and personal clinical and family history as well as symptom constellation and physical exam findings. Can these all be integrated into a single personalized profile ...more »

Voting

1 net vote
2 up votes
1 down votes
Active